Myelotib 150mg Tablet
Marketer
Delarc Pharmaceuticals Private Limited
Salt Composition
Nilotinib (150mg)
Overview Myelotib 150mg Tablet
Chronic myeloid leukemia (CML) patients whose condition doesn't respond to, or is intolerant of, other treatments may benefit from Myelotib 150mg tablets. Administer this medication on an empty stomach, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on individual needs and may be adjusted. Strict adherence to your doctor's prescribed regimen is crucial, as incorrect usage or overdosage can lead to severe adverse effects. While therapeutic benefits might not be immediately apparent (weeks or months), discontinue use only under medical guidance. Common side effects include headache, nausea, abdominal pain, and rash. Severe diarrhea necessitates immediate medical attention or increased fluid intake. Myelotib can reduce blood cell counts (red and white), potentially increasing infection risk; therefore, regular blood tests monitoring blood cell levels, heart, liver, uric acid, blood sugar, and fat levels are mandatory. Inform your doctor of pre-existing heart, liver, or kidney conditions, or any concurrent medications, especially those for infections, before starting treatment. Interactions with numerous other drugs are possible, so disclose all medications to your healthcare provider. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception for both partners is essential throughout treatment.
Uses of Myelotib 150mg Tablet
Chronic myelogenous leukemia, a type of blood malignancy
Major Benefits of Myelotib 150mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Myelotib 150mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.
Common Side effects of Myelotib 150mg Tablet:
- Headache
- Nausea
- Abdominal pain
- Rash
- Itching
- Hair loss
- Muscle pain
- Fatigue
How to use Myelotib 150mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Myelotib 150mg Tablet on an empty stomach.
How Myelotib 150mg Tablet works:
Myelotib 150mg tablets are an anticancer drug that inhibits the activity of a faulty protein responsible for cancerous cell proliferation, thereby hindering or slowing the growth of malignant cells.
SAFETY ADVICE
AlcoholSAFE
Myelotib 150mg Tablet use alongside alcohol consumption poses no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Using Myelotib 150mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, its use is discouraged. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Myelotib 150mg tablets are incompatible. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Taking a 150mg Myelotib tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Use of the 150mg Myelotib tablet in patients with kidney disease appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverCAUTION
Individuals with hepatic impairment should use 150mg Myelotib tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Myelotib 150mg Tablet :
Omit any missed Myelotib 150mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Myelotib 150mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine-amine derivative |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Behavior Class | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently